The patients’ blood is used to directly determine the presence or absence of pathogenic germline variants in the mismatch repair genes and 3′ deletions of EPCAM. If a pathogenic variant is identified, the patient is diagnosed with Lynch syndrome. The gene discussed is EPCAM; the disease is Lynch syndrome.